98%
921
2 minutes
20
Purpose: Recurrent cystitis guidelines recommend relying on a local antibiogram or prior urine culture to guide empirical prescribing, yet little data exist to quantify the predictive value of a prior culture. We constructed a urinary antibiogram and evaluated test metrics (sensitivity, specificity, and Bayes' positive and negative predictive values) of a prior gram-negative organism on predicting subsequent resistance or susceptibility among patients with uncomplicated, recurrent cystitis.
Materials And Methods: We performed a retrospective database study of adults with recurrent, uncomplicated cystitis (cystitis occurring 2 times in 6 months or 3 times in 12 months) from urology or primary care clinics between November 1, 2016, and December 31, 2018. We excluded pregnant females, patients with complicated cystitis, or pyelonephritis. Test metrics were calculated between sequential, paired cultures using standard formulas.
Results: We included 597 visits from 232 unique patients wherein 310 (51.2%) visits had a urine culture and 165 had gram-negative uropathogens isolated. Patients with gram-negative uropathogens were mostly females (97%), with a median age of 58.5 years. Our antibiogram found 38.0%, 27.9%, and 5.5% of isolates had resistance to trimethoprim-sulfamethoxazole, ciprofloxacin, and nitrofurantoin, respectively. Prior cultures (within 2 years) had good predictive value for detecting future susceptibility to first-line agents nitrofurantoin (0.85) and trimethoprim-sulfamethoxazole (0.78) and excellent predictive values (≥0.90) for cefepime, ceftriaxone, cefuroxime, ciprofloxacin, levofloxacin, gentamicin, tobramycin, piperacillin-tazobactam, and imipenem.
Conclusions: Considerable antibiotic resistance was detected among isolates in patients with recurrent, uncomplicated cystitis. Using a prior culture as a guide can enhance the probability of selecting an effective empirical agent.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/JU.0000000000003744 | DOI Listing |
Palliat Med Rep
June 2025
Department of Oncology, McMaster University, Hamilton, Ontario, Canada.
Background: Community Access to Palliative Care via Interprofessional Teams Improvement (CAPACITI) is a virtual educational program designed to support primary care providers in delivering a palliative approach to care. This study evaluated whether expert-facilitated sessions result in greater self-rated competency than a self-directed format across three CAPACITI modules: Identification and Assessment, Communication, and Ongoing Management.
Methods: We conducted a randomized controlled trial where 566 interprofessional primary care team members were randomized to facilitated or self-directed delivery of the CAPACITI program.
Health Equity
August 2025
Facultad de Odontología, Universidad de los Andes, Las Condes, Chile.
Background: Oral cancer is one of the 10 most common cancers globally and represents a public health problem. Cultural practices and access to care are recognized as determinants of oral diseases, including cancer. Understanding the perceptions of indigenous communities is crucial for developing culturally appropriate interventions.
View Article and Find Full Text PDFHealth Equity
August 2025
Faculty of Health, National Centre for Naturopathic Medicine, Southern Cross University, Lismore, New South Wales, Australia.
Background: Reproductive health, including menstrual health, is a critical element of the overall well-being of women. Knowledge of menstrual health increases personal empowerment and self-care. This review explores adult women's knowledge of menstrual and reproductive health.
View Article and Find Full Text PDFBiosaf Health
August 2025
Departamento de Especialidades Médicas, Instituto Nacional de Enfermedades Neoplásicas, Surquillo 15038, Perú.
Healthcare-associated infections are linked with the contamination of inanimate surfaces and the air in occupied hospital areas by recognized pathogens. However, there is limited information about the presence of these microorganisms or other potential pathogens in critical areas prior to their clinical operation. Here, we determined the microbial community in critical areas prior to their validation for hospital care and reviewed the background for the potential pathogenic role of this microbiota for populations susceptible to opportunistic infections.
View Article and Find Full Text PDFMol Ther Methods Clin Dev
September 2025
UMR 1098 RIGHT INSERM/Etablissement Français du Sang Bourgogne Franche-Comté/Université Marie et Louis Pasteur, 25000 Besançon, France.
Despite the clinical success of redirected T cells in the setting of cancer adoptive cell immunotherapy, patients may exhibit resistance to treatment, resulting in uncontrolled disease and relapses. This phenomenon partly relies on impaired -produced T cell metabolic fitness, including a decreased respiratory reserve, as well as a greater sensitivity to tumor-mediated metabolic stress. To improve the respiratory capacity of cultured T cells, we sought to target the nicotinamide adenine dinucleotide/sirtuine-1/reactive oxygen species (ROS) axis through supplementation of culture medium with resveratrol.
View Article and Find Full Text PDF